RICHMOND, Va. – Phlow Corp., a public benefit essential medicines solutions provider, and the United States Pharmacopeia (USP) have announced a strategic alliance to develop a new laboratory that will certify and validate Pharmaceutical Continuous Manufacturing processes resulting in affordable, high-quality, U.S.-manufactured essential medicines. Throughout its 200-year history of setting standards for medicine quality, USP
Ronald Piervincenzi, chief executive officer of the United States Pharmacopeia, discusses the organization’s mission, new modalities of medicine and pharmacy’s role in the health care continuum in this week’s installment of our Video Forum.
This year marks an important milestone for USP — and the entire health care sector. As we celebrate our 200th anniversary and gear up for our 2020 Convention, it’s an appropriate time to look at the work we’ve done and what lies ahead of us. From new technologies such as digital therapeutics, immunotherapy and artificial
